NASDAQ: TELO
Telomir Pharmaceuticals Inc Stock Ownership - Who owns Telomir Pharmaceuticals?

Insider buying vs selling

Have Telomir Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Erez AminovCEO and Chairman2026-04-227,319,710$1.37
$10.03MBuy

1 of 1

TELO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TELO insiders and whales buy or sell their stock.

TELO Shareholders

What type of owners hold Telomir Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Erez Aminov10.64%7,319,710$9.52MInsider
Mira Pharmaceuticals Inc5.12%3,521,127$4.58MInsider
Shore Trust Bay4.79%3,292,696$4.28MInsider
Vanguard Capital Management LLC1.45%995,373$1.29MInstitution
Christopher C. Chapman Jr.1.42%975,610$1.27MInsider
Craig Eagle0.71%487,805$634.15kInsider
Blackrock Inc0.42%289,198$375.96kInstitution
Geode Capital Management LLC0.36%249,086$323.81kInstitution
Vanguard Fiduciary Trust Co0.20%135,541$176.20kInstitution
Millennium Management LLC0.19%129,060$167.78kInstitution

1 of 3

TELO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TELO3.26%23.07%Net BuyingNet Buying
ATHE0.00%0.17%
LONA34.44%65.56%Net BuyingNet Selling
AARD46.75%46.87%Net Buying
CUE77.22%22.78%Net Buying

Telomir Pharmaceuticals Stock Ownership FAQ

Who owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals (NASDAQ: TELO) is owned by 3.26% institutional shareholders, 23.07% Telomir Pharmaceuticals insiders, and 73.67% retail investors. Erez Aminov is the largest individual Telomir Pharmaceuticals shareholder, owning 7.32M shares representing 10.64% of the company. Erez Aminov's Telomir Pharmaceuticals shares are currently valued at $9.52M.

If you're new to stock investing, here's how to buy Telomir Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.